Accelerating the commercialisation of a disruptive analytical technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence

Risultati finali

Ensuring that Valitacell product and associated has the required CE registration

Submission of results and outline of applicability and benefits of technology in a report to be published in a peer reviewed journal or online publication

Results exchanged

Review of the results from the four sites and analysis of same in order to determine the final model to be adopted in the product

Pubblicazioni

High-throughput quantitation of Fc-containing recombinant proteins in cell culture supernatant by fluorescence polarization spectroscopy

Autori: Ben Thompson, Jerry Clifford, Mike Jenns, Andrew Smith, Ray Field, Kalpana Nayyar, David C. James
Pubblicato in: Analytical Biochemistry, Numero 534, 2017, Pagina/e 49-55, ISSN 0003-2697
Editore: Academic Press
DOI: 10.1016/j.ab.2017.07.013

Diritti di proprietà intellettuale

A METHOD OF MEASURING ANTIBODY CONCENTRATION IN A SAMPLE

Numero candidatura/pubblicazione: EP 15736411
Data: 2015-06-18
Candidato/i: VALITACELL LTD

A METHOD OF PREDICTING PHENOTYPIC INSTABILITY IN A CELL

Numero candidatura/pubblicazione: EP 15718799
Data: 2015-04-02
Candidato/i: VALITACELL LTD

A METHOD OF MEASURING ANTIBODY CONCENTRATION IN A SAMPLE

Numero candidatura/pubblicazione: EP 15736411
Data: 2015-06-18
Candidato/i: VALITACELL LTD

A METHOD OF PREDICTING PHENOTYPIC INSTABILITY IN A CELL

Numero candidatura/pubblicazione: EP 15718799
Data: 2015-04-02
Candidato/i: VALITACELL LTD

chemstress

Numero candidatura/pubblicazione: TM 017262511
Data: 2018-02-12
Candidato/i: VALITACELL LTD

chemstress

Numero candidatura/pubblicazione: TM 017262511
Data: 2018-02-12
Candidato/i: VALITACELL LTD

A METHOD OF PREDICTING RELATIVE FED BATCH PRODUCTION TITER OF A PANEL OF CLONALLY-DERIVED PRODUCER CELLS

Numero candidatura/pubblicazione: EP 14830805
Data: 2014-12-17
Candidato/i: VALITACELL LTD